Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications

被引:889
作者
D'souza, Anisha A. [1 ]
Shegokar, Ranjita [2 ]
机构
[1] Indian Inst Technol, Dept Biosci & Bioengn, Mumbai, Maharashtra, India
[2] Free Univ Berlin, Inst Pharm, Dept Pharmaceut Biopharmaceut & NutriCosme, Kelchstr 31, D-12169 Berlin, Germany
关键词
Polyethylene glycol (PEG); liposomes; nanoparticles; stealth effect; permeation enhancer; plasticizer; polymer; solubilizers; nanotoxicity; surface modification/decoration; VITRO CELL-INTERACTION; TRI-BLOCK COPOLYMERS; POLY(ETHYLENE GLYCOL); DRUG-DELIVERY; IN-VITRO; TRIBLOCK COPOLYMER; PACLITAXEL PRODRUG; CONTROLLED-RELEASE; SOLID DISPERSIONS; PLGA COPOLYMERS;
D O I
10.1080/17425247.2016.1182485
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Polyethylene glycol (PEG) is a polymer of choice in drug delivery systems. This USFDA-approved polymer is popular due to its tunable properties and well-established safety profile: prime requisites considered during the selection of any excipient in formulation development. Areas covered: The unique properties and applications of PEG have been discussed at length in the existing literature. However, a proper guidance on selection of PEG grade to cater to one's purpose is lacking. This article provides preliminary guidelines to formulators on selection of appropriate PEG grade, typically based on its physico-chemical properties and role-based functional application in pharmaceuticals. It should be noted that the aim article is not to deep dive in each application area. Expert opinion: Guidance on PEG application and grade of choice is lacking in the available literature. The authors have discussed and provided guidance to formulators on the appropriate PEG grade selection for particular application based on the available in vitro and in vivo literature data. In this review a State-of-the-art use of PEG in therapeutic applications, its clinical status and commercial use is also summarized. Nevertheless, toxicities related to different PEG grades and related impurities are discussed in this review.
引用
收藏
页码:1257 / 1275
页数:19
相关论文
共 158 条
[1]   The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage [J].
Abu Lila, Amr S. ;
Kiwada, Hiroshi ;
Ishida, Tatsuhiro .
JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) :38-47
[2]  
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
[3]   Poly(ethylene glycol)-poly(lactic-co-glycolic acid) based thermosensitive injectable hydrogels for biomedical applications [J].
Alexander, Amit ;
Ajazuddin ;
Khan, Junaid ;
Saraf, Swarnlata ;
Saraf, Shailendra .
JOURNAL OF CONTROLLED RELEASE, 2013, 172 (03) :715-729
[4]  
[Anonymous], 2002, The MAK-Collection for Occupational Health and Safety, DOI DOI 10.1002/3527600418.MB2532268KSKE0010
[5]  
[Anonymous], 2003, EMEACPMPBWP306803
[6]  
[Anonymous], 2009, ROLE LUBRICANTS SOLI
[7]  
Authority EFS, 2006, EFSA J
[8]   Neutral and anionic liposome-encapsulated hemoglobin: Effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics [J].
Awasthi, VD ;
Garcia, D ;
Klipper, R ;
Goins, BA ;
Phillips, WT .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01) :241-248
[9]   Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers [J].
Bae, Younsoo ;
Kataoka, Kazunori .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (10) :768-784
[10]   Effect of PEGylation on Biodistribution and Gene Silencing of siRNA/Lipid Nanoparticle Complexes [J].
Bao, Yanjie ;
Jin, Yi ;
Chivukula, Padmanabh ;
Zhang, Jun ;
Liu, Yun ;
Liu, Jian ;
Clamme, Jean-Pierre ;
Mahato, Ram I. ;
Ng, Dominic ;
Ying, Wenbin ;
Wang, Yiting ;
Yu, Lei .
PHARMACEUTICAL RESEARCH, 2013, 30 (02) :342-351